Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Injectable GHK-Cu is increasingly used in scalp-injection protocols alongside other hair-loss peptides
As AI becomes increasingly prevalent in both research and clinical applications, a range of ethical and regulatory challenges has emerged
Some research protocols have explored doses up to 4.5 mg weekly, which showed slightly greater efficacy in the phase 2 dose-finding trial but also increased side effect burden
SS-31 (Elamipretide) SS-31 is a mitochondria-targeting peptide designed to support mitochondrial membrane integrity and energy production
Additionally, BPC-157 is employed in advanced research focused on inflammatory signalling modulation, cytoskeletal repair, and cellular communication networks
No Phase 1 or Phase 2 trial has been conducted for PDA as a distinct compound
US$ 23.11
US$ 28.92
US$ 28.25
US$ 27.98
US$ 21.47
US$ 22.06
US$ 24.60
US$ 24.19
